AltekruseSF, RosenfeldGE, CarrickDM, et al.SEER cancer registry biospecimen research: Yesterday and tomorrow. Cancer Epidemiol Biomarkers Prev, 2014; 23:2681–2687.
3.
SEER Website. National Cancer Institute's Surveillance, Epidemiology, and End-Result program. Available at https://seer.cancer.gov/ (Last accessed June6, 2018).
4.
GreytakSR, EngelKB, BassBP, et al.Accuracy of molecular data generated with FFPE biospecimens: Lessons from the literature. Cancer Res, 2015; 75:1541–1547.
5.
BassBP, EngelKB, GreytakSR, et al.A review of pre-analytical factors affecting molecular, protein, and morphological analysis of formalin-fixed, paraffin-embedded tissue. Arch Pathol Lab Med, 2014; 138:1520–1530.
6.
KratzA, CarninciP. The devil in the details of RNA-seq. Nat Biotechnol, 2014; 32:882–884.
7.
KimS, ParkC, JiY, et al.Deamination effects in formalin-fixed, paraffin-embedded tissue samples in the era of precision medicine. J Mol Diagn, 2017; 19:137–146.
8.
Biospecimen Research Database. National Cancer Institute, Biorepositories and Biospecimen Research Branch. Available at https://brd.nci.nih.gov/ (Last accessed July6, 2018).
9.
MassettHA, AtkinsonNL, WeberD, et al.Assessing the need for a standardized cancer HUman Biobank (caHUB): Findings from a national survey with cancer researchers. J Natl Cancer Inst Monogr, 2011; 2011:8–15.
